Current diagnostic methods for diisocyanate induced occupational asthma

American Journal of Industrial Medicine

Volumn 36, Issue 4, 1999, Pages 459-468

  Bernstein, David I ^b   Jolly, Athena ^a  

^a Occup and Environmental Health   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Diagnostic guidelines; Diisocyanate; Diisocyanate asthma; Occupational asthma; Specific bronchoprovocation test

Indexed keywords

IMMUNOGLOBULIN E; ISOCYANIC ACID DERIVATIVE;

ARTICLE; DIAGNOSTIC VALUE; HUMAN; IMMUNOLOGICAL PROCEDURES; INTERMETHOD COMPARISON; LUNG FUNCTION TEST; OCCUPATIONAL ASTHMA; OCCUPATIONAL EXPOSURE; PRACTICE GUIDELINE; PROVOCATION TEST; SEROLOGY;

ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; CROSS-LINKING REAGENTS; CYANATES; HUMANS; IMMUNOGLOBULIN E; ISOCYANATES; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PEAK EXPIRATORY FLOW RATE; POLYMERS; REPRODUCIBILITY OF RESULTS;

EID: 0032858856     PISSN: 02713586     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0274(199910)36:4<459::AID-AJIM7>3.0.CO;2-W     Document Type: Article

References (35)

1. ACCP Consensus Statement: Assessment of Asthma in the Workplace. 1995. Chest 108:1084-1117.
2. American Thoracic Society. Standardization of Spirometry: 1994 Update. 1995. Am J Respir Crit Care Med 152:1107-1136.
3. Baur X, Huber H, Degens PO, Allmers H, Amman J. 1998. Relation between occupational asthma case history, bronchial methacholine challenge and specific challenge test in patients with suspected occupational asthma. Am J Ind Med 33:114-122.
4. Bernstein DI, editor. Guidelines for the Diagnosis and Evaluation of Occupational Immunologic Lung Disease. 1989. J Allergy Clin Immunol (supplement) 84:3A-6A and 701-844.
5. Bernstein DI. 1993. Clinical assessment and management of occupational asthma. In: Bernstein IL, Chang-Yeung M, Malo J-L et al., editors. Asthma in the Workplace. New York: Marcel Dekker, Inc. 103 p.
6. Bernstein DI, Korbee L, Stauder T, Bernstein JA, Bernstein IL. 1993. The low prevalence of occupational asthma and antibody dependent sensitization to diphenylmethane diisocyanate (MDI) in a plant engineered for minimal exposure to diisocyanates. J Allergy Clin Immunol 92:387-396.
7. Bernstein IL. 1982. Isocyanate-induced pulmonary disease: A current perspective. J Allergy Clin Immunol 70:24-32.
8. Bernstein IL, et al. 1993. Definition and classification of asthma. In: Bernstein IL, Chan-Yeung M, Malo J-L, et al., editors. Asthma in the workplace. New York: Marcel Dekker, Inc. p 1-4.
9. Butcher B, Bernstein IL, Schwartz HJ. 1989. Guidelines for the clinical evaluation of occupational asthma due to small molecular weight chemicals. J Allergy Clin Immunol (supplement) 84:834-38.
10. Butcher BT, Karr RM, O'Neill, et al., 1976. Toluene diisocyanate pulmonary disease: Immunologic and inhalation challenge studies of TDI sensitive workers. J Allergy Clin Immunol 58(1):89-100.
11. Butcher BT, O'Neil CE, Reed MA, Salvaggio JE, Weill H. 1982. Development and loss of toluene diisocyanate (TDI) reactivity: immunologic, pharmacologic and provocative inhalation challenge studies. J Allergy Clin Immunol 70:231.
12. Cartier A, Bernstein IL, Burge PS, et al. 1989. Guidelines for bronchoprovocation on the investigation of occupational asthma. J Allergy Clin Immunol (supplement). 84:823-829.
13. Cartier A, Grammar L, Malo J-L, et al. 1989. Specific serum antibodies against isocyanates: association with occupational asthma. J Allergy Clin Immunol 84:507-514.
14. 20 determination in a random selection of young college students. J Allergy Clin Immunol 89:23.
15. Durham SR, et al. 1987. The temporal relationship between increases in airway hyperresponsiveness to histamine and late asthmatic responses induced by occupational agents. J Allergy Clin Immunol 79:398-406.
16. Gallagher JS, Tse CST, Brooks SM, Bernstein IL. 1981. Diverse profiles in immunoreactivity in toluene diisocyanate (TDI) asthma. J Occup Med 23:610-616.
17. Gannon PFG, Dickinson SA, Hitchings DJ, Burge PS. 1993. The quality of self-recorded peak expiratory flow (PEF). Eur Resp J 6:492S.
18. Health and Safety Executive (1991) (MS25). 1992. Medical aspects of occupational asthma. HSE Books. ISBN 0 11 885584 0.
19. Liss GM, Bernstein DI, Moller DR, Gallagher JS, Stephenson RS, Bernstein IL. 1988. Pulmonary and immunologic evaluation of foundry workers exposed to methylene diphenyldiisocyanate (MDI). J Allergy Clin Immunol 82:55-61.
20. Lushniak BD, Reh CM, Bernstein DI, Gallagher JS. 1998. Indirect assessment of 4,4-diphenyl-methane diisocyanate (MDI) exposure by evaluation of specific humoral immune responses to MDI conjugated to human serum albumin (HSA). Am J Ind Med 33:471-477.
21. Malo J-L, Cote J, Cartier A, Boulet L-P, L'Archeveque JL, Chan-Yeung M. 1993. How many times per day should peak expiratory flow rates be assessed when investigating occupational asthma? Thorax 48:1211-1217.
22. Malo J-L, Ghezzo H, L'Archeveque J, Lagier F, Perrin B, Cartier A. 1991. Is the clinical history a satisfactory means of diagnosing occupational asthma? Am Rev Resp Dis 143:528-532.
23. Mapp CE, Boschetto P, Dal Vecchio L, Maestrelli P, Fabbri LM. 1988. Occupational asthma due to isocyanates. Eur Respir J 1:273-279.
24. Meredith SK, Taylor VM, McDonald JC. 1989. Occupational respiratory disease in the United Kingdom 1989: a report to the British Thoracic Society and the Society of Occupational Medicine by the SWORD project group. Br J Ind Med 48:292-298.
25. Moscato G, Godnic-Cvar J, Maestrelli. 1995. Statement on self-monitoring of peak expiratory flows in the investigation of occupational asthma. Subcommittee on Occupational Allergy of European Academy of Allergy and Clinical Immunology. J Allergy Clin Immunol 96(3):295.
26. O'Brien IM, Newman-Taylor AJ, Burge PS, Harries MG, Fawcett IW, Pepys J. 1979. Toluene diisocyanate asthma. II. Inhalation challenge tests and bronchial reactivity studies. Clin Allergy 9:7-15
27. Perrin B, Cartier A, Ghezzo H, Grammar L, Harris K, Chan H, ChanYeung M, Malo J-L. 1991. Reassessment of the temporal patterns of bronchial obstruction after exposure to occupational sensitizing agents. J Allergy Clin Immunol 87:630-639.
28. Perrin B, Lagier F, L'Archeveque J, Cartier A, Boulet LP, Cote J, Malo J-L. 1992. Occupational asthma; validity of monitoring of peak expiratory flow rates and non-allergic bronchial responsiveness as compared to specific inhalation challenge. Eur Resp J 5:40-48.
29. Quirce S, Contreras G, Dybuncio A, Chan-Yeung M. 1995. Peak expiratory flow monitoring is not a reliable method for establishing the diagnosis of occupational asthma. Am Resp Crit Care Med 152: 1100-1102.
30. Sterk PJ, Fabbri LU, Quanjer PH, Cockcroft DW, O'Byrne PM, Anderson SD, Juniper EF, Malo J-L. 1993. Airway responsiveness: standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Resp J 6 (Suppl) 16: 53-83.
31. Subcommittee on occupational allergy. 1992. Maestrelli P. (chairman). Guidelines for the diagnosis of occupational asthma. Clin Exp Allergy 22:103-108.
32. Tarlo SM, Boulet L-P, Carrier A, et al. 1998. Canadian Thoracic Society guidelines for occupational asthma. Can Respir J 5(4): 289-300.
33. Tee RD, Cullinan P, Welch J, Burge PS, Newman-Taylor AJ. 1998. Specific IgE to isocyanates: A useful diagnostic role in occupational asthma. J Allergy Clin Immunol 101:709-715.
34. Vandenplas O, Malo J-L, Cartier A, Perrault G, Cloutier Y. 1992. Closed-circuit methodology for inhalation challenge tests with isocyanates. Am Rev Resp Dis 145:582-587.
35. Zammit Tabona M, Sherkin M, Kijek K, Chan H, Chan-Yeung M. 1983. Asthma caused by diphenylmethane diisocyanate. Am Rev Resp Dis 128:226.